{
  "id": [
    "33455472"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "33455472"
  ],
  "pmcid": [
    "PMC7822064"
  ],
  "fullTextIdList": [
    {
      "fullTextId": [
        "PMC7822064"
      ]
    }
  ],
  "doi": [
    "10.1080/14756366.2020.1870456"
  ],
  "title": [
    "Thiophen urea derivatives as a new class of hepatitis C virus entry inhibitors."
  ],
  "authorString": [
    "Ryu HC, Windisch M, Lim JW, Choi I, Lee EK, Yoo HH, Kim TK."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Ryu HC"
          ],
          "firstName": [
            "Hyung Chul"
          ],
          "lastName": [
            "Ryu"
          ],
          "initials": [
            "HC"
          ],
          "authorAffiliationDetailsList": [
            {
              "authorAffiliation": [
                {
                  "affiliation": [
                    "R&D Center, J2H Biotech, Suwon, Gyeonggi-do, Republic of Korea."
                  ]
                }
              ]
            }
          ]
        },
        {
          "fullName": [
            "Windisch M"
          ],
          "firstName": [
            "Marc"
          ],
          "lastName": [
            "Windisch"
          ],
          "initials": [
            "M"
          ],
          "authorAffiliationDetailsList": [
            {
              "authorAffiliation": [
                {
                  "affiliation": [
                    "Medicinal Chemistry, Institut Pasteur Korea, Seongnam, Gyeonggi-do, Republic of Korea."
                  ]
                }
              ]
            }
          ]
        },
        {
          "fullName": [
            "Lim JW"
          ],
          "firstName": [
            "Jee Woong"
          ],
          "lastName": [
            "Lim"
          ],
          "initials": [
            "JW"
          ],
          "authorAffiliationDetailsList": [
            {
              "authorAffiliation": [
                {
                  "affiliation": [
                    "R&D Center, J2H Biotech, Suwon, Gyeonggi-do, Republic of Korea."
                  ]
                }
              ]
            }
          ]
        },
        {
          "fullName": [
            "Choi I"
          ],
          "firstName": [
            "Inhee"
          ],
          "lastName": [
            "Choi"
          ],
          "initials": [
            "I"
          ],
          "authorAffiliationDetailsList": [
            {
              "authorAffiliation": [
                {
                  "affiliation": [
                    "Medicinal Chemistry, Institut Pasteur Korea, Seongnam, Gyeonggi-do, Republic of Korea."
                  ]
                }
              ]
            }
          ]
        },
        {
          "fullName": [
            "Lee EK"
          ],
          "firstName": [
            "Eun Kyu"
          ],
          "lastName": [
            "Lee"
          ],
          "initials": [
            "EK"
          ],
          "authorAffiliationDetailsList": [
            {
              "authorAffiliation": [
                {
                  "affiliation": [
                    "Institute of Pharmaceutical Science and Technology and College of Pharmacy, Hanyang University, Ansan, Gyeonggi-do, Republic of Korea."
                  ]
                }
              ]
            }
          ]
        },
        {
          "fullName": [
            "Yoo HH"
          ],
          "firstName": [
            "Hye Hyun"
          ],
          "lastName": [
            "Yoo"
          ],
          "initials": [
            "HH"
          ],
          "authorAffiliationDetailsList": [
            {
              "authorAffiliation": [
                {
                  "affiliation": [
                    "Institute of Pharmaceutical Science and Technology and College of Pharmacy, Hanyang University, Ansan, Gyeonggi-do, Republic of Korea."
                  ]
                }
              ]
            }
          ]
        },
        {
          "fullName": [
            "Kim TK"
          ],
          "firstName": [
            "Tae Kon"
          ],
          "lastName": [
            "Kim"
          ],
          "initials": [
            "TK"
          ],
          "authorAffiliationDetailsList": [
            {
              "authorAffiliation": [
                {
                  "affiliation": [
                    "College of Science and Engineering, Jungwon University, Geosan-gun, Chungbuk, Republic of Korea."
                  ]
                }
              ]
            }
          ]
        }
      ]
    }
  ],
  "journalInfo": [
    {
      "issue": [
        "1"
      ],
      "volume": [
        "36"
      ],
      "journalIssueId": [
        "3043283"
      ],
      "dateOfPublication": [
        "2021 Dec"
      ],
      "monthOfPublication": [
        "12"
      ],
      "yearOfPublication": [
        "2021"
      ],
      "printPublicationDate": [
        "2021-12-01"
      ],
      "journal": [
        {
          "title": [
            "Journal of enzyme inhibition and medicinal chemistry"
          ],
          "ISOAbbreviation": [
            "J Enzyme Inhib Med Chem"
          ],
          "medlineAbbreviation": [
            "J Enzyme Inhib Med Chem"
          ],
          "NLMid": [
            "101150203"
          ],
          "ISSN": [
            "1475-6366"
          ],
          "ESSN": [
            "1475-6374"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2021"
  ],
  "pageInfo": [
    "462-468"
  ],
  "abstractText": [
    "To develop unique small-molecule inhibitors of hepatitis C virus (HCV), thiophen urea (TU) derivatives were synthesised and screened for HCV entry inhibitory activities. Among them, seven TU compounds exhibited portent anti-viral activities against genotypes 1/2 (EC<sub>50</sub> < 30â€‰nM) and subsequently, they were further investigated; based on the pharmacological, metabolic, pharmacokinetic, and safety profiles, <b>J2H-1701</b> was selected as the optimised lead compound as an HCV entry inhibitor. <b>J2H-1701</b> possesses effective multi-genotypic antiviral activity. The docking results suggested the potential interaction of <b>J2H-1701</b> with the HCV E2 glycoprotein. These results suggest that <b>J2H-1701</b> can be a potential candidate drug for the development of HCV entry inhibitors."
  ],
  "affiliation": [
    "R&D Center, J2H Biotech, Suwon, Gyeonggi-do, Republic of Korea."
  ],
  "publicationStatus": [
    "ppublish"
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Print"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "brief-report",
        "Journal Article"
      ]
    }
  ],
  "keywordList": [
    {
      "keyword": [
        "Hepatitis C virus",
        "Small Molecule",
        "Entry Inhibitor",
        "Thiophen Urea"
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "https://doi.org/10.1080/14756366.2020.1870456"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7822064"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7822064?pdf=render"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "N"
  ],
  "citedByCount": [
    "0"
  ],
  "hasData": [
    "N"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "N"
  ],
  "license": [
    "cc by"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "N"
  ],
  "dateOfCreation": [
    "2021-01-18"
  ],
  "firstIndexDate": [
    "2021-01-19"
  ],
  "fullTextReceivedDate": [
    "2021-02-01"
  ],
  "dateOfRevision": [
    "2021-01-30"
  ],
  "firstPublicationDate": [
    "2021-12-01"
  ]
}